The Hematologist: Update on the ASH Research Collaborative Data Hub
Dr. William Wood provided an update on the ASH Research Collaborative Data Hub in a recent issue of the Hematologist.
This author has not written his bio yet.
But we are proud to say that admin contributed 47 entries already.
Dr. William Wood provided an update on the ASH Research Collaborative Data Hub in a recent issue of the Hematologist.
The ASH Research Collaborative (ASH RC) has collaborated with two industry leaders, Novartis Pharmaceuticals Corporation (Novartis) and Amgen, to include de-identified patient data from three separate studies of nearly 500 patients living with Sickle Cell Disease (SCD) and more than 1,000 patients with multiple myeloma as part of an unprecedented data sharing initiative.
The ASH Research Collaborative’s Sickle Cell Disease (SCD) Clinical Trials Network (CTN) patient-centered approach was recently featured in Media Planet’s Clinical Trials issue.
The ASH Research Collaborative Leadership provides a progress report on the development of the Sickle Cell Disease Clinical Trials Network.
The Sickle Cell Disease Clinical Trials Network’s ambitious goal of accelerating development of novel therapies for patients with sickle cell disease was covered by HemOnc Today.
ASH Clinical News featured an announcement that ASH would be creating a sickle cell disease (SCD) clinical trials network to accelerate the development of new therapies.
Dr. Charles Chesson provided an update on the ASH Research Collaborative Data Hub in a recent issue of the Hematologist.
Mailing Address
ASH Research Collaborative
2021 L Street NW, Suite 900
Washington, DC 20036
Toll Free Phone
+1 (866) 828.1231
E-mail
info@ashrc.org
